The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Cyclin D1, cancer progression, and opportunities in cancer treatment
Open accessAbstract
Mammalian cells encode three D cyclins (D1, D2, and D3) that coordinately function as allosteric regulators of cyclin-dependent kinase 4 (CDK4) and CDK6 to regulate cell cycle transition from G1 to S phase. Cyclin expression, accumulation, and degradation, as well as assembly and activation of CDK4/CDK6 are governed by growth factor stimulation. Cyclin D1 is more frequently dysregulated than cyclin D2 or D3 in human cancers, and as such, it has been more extensively characterized. Overexpression of cyclin D1 results in dysregulated CDK activity, rapid cell growth under conditions of restricted mitogenic signaling, bypass of key cellular checkpoints, and ultimately, neoplastic growth. This review discusses cyclin D1 transcriptional, translational, and post-translational regulations and its biological function with a particular focus on the mechanisms that result in its dysregulation in human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
Harding, H. P., Zhang, Y., & Ron, D. (1999) · Nature · doi:10.1038/16729 · Cited by 3,310
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Self-citationHarding, H. P., Zhang, Y., Bertolotti, A., Zeng, H., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80330-5 · Cited by 2,021
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,415
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Cyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG Pathway
Lavoie, J. N., L'Allemain, G., Brunet, A., Müller, R., & Pouysségur, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20608 · Cited by 1,211
CDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152
D-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentinc, M., Draetta, G. F., Jessup, J. M., & Pagano, M. (1997) · Nature Medicine · doi:10.1038/nm0297-231 · Cited by 1,031
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 941
Targeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936 · cited 4×
“Besides breast cancers, these inhibitors are undergoing extensive investigations in various clinical trials; the activities and efforts to evaluate CDK4/CDK6 inhibitors in a variety of indications have recently been reviewed in depth [1].”
BackgroundInfluentialSpecific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
The front and rear of collective cell migration
Mayor, R., & Etienne-Manneville, S. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.14 · Cited by 877
Shi, Y., Vattem, K. M., Sood, R., An, J., Liang, J., Stramm, L., & Wek, R. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7499 · Cited by 774
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 1×
“Mutation of this threonine to a non-phosphorylatable residue dramatically stabilizes cyclin D1, inhibits its nuclear export, and triggers the constitutive activation of CDK4/CDK6 within the nuclear compartment [12, 35, 36].”
BackgroundSelf-citationSystematic analysis and nomenclature of mammalian F-box proteins
Jin, J., Cardozo, T., Lovering, R. C., Elledge, S. J., Pagano, M., & Harper, J. W. (2004) · Genes & Development · doi:10.1101/gad.1255304 · Cited by 712
Pal, S., Vishwanath, S. N., Erdjument-Bromage, H., Tempst, P., & Sif, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9630-9645.2004 · Cited by 592
Anders, L., Ke, N., Hydbring, P., Choi, Y. J., Widlund, H. R., Chick, J. M., Zhai, H., Vidal, M., Gygi, S. P., Braun, P., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.001 · Cited by 543 · cited 2×
“resulting in cell cycle re-entry and suppression of senescence in melanoma cells but not in melanocytes [83].”
BackgroundAlt, J. R., Cleveland, J. L., Hannink, M., & Diehl, J. A. (2000) · Genes & Development · doi:10.1101/gad.854900 · Cited by 535
Self-citationCyclin-dependent kinases regulate the antiproliferative function of Smads
Matsuura, I., Denissova, N. G., Wang, G., He, D., Long, J., & Liu, F. (2004) · Nature · doi:10.1038/nature02650 · Cited by 503
A single NFκB system for both canonical and non-canonical signaling
Shih, V. F.-S., Tsui, R., Caldwell, A., & Hoffmann, A. (2011) · Cell Research · doi:10.1038/cr.2010.161 · Cited by 499
Cheng, M., Sexl, V., Sherr, C. J., & Roussel, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1091 · Cited by 496
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase
Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., & Hershko, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301774200 · Cited by 494
E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression
Chen, C.-R., Kang, Y., Siegel, P. M., & Massagué, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00801-2 · Cited by 487
PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling
Lin, X., Duan, X., Liang, Y.-Y., Su, Y., Wrighton, K. H., Long, J., Hu, M., Davis, C. M., Wang, J., Brunicardi, F. C., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.044 · Cited by 485
A census of amplified and overexpressed human cancer genes
Santarius, T., Shipley, J., Brewer, D., Stratton, M. R., & Cooper, C. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2771 · Cited by 482
PERK mediates cell-cycle exit during the mammalian unfolded protein response
Brewer, J. W., & Diehl, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220247197 · Cited by 463
Self-citationArginine methylation regulates the p53 response
Jansson, M., Durant, S. T., Cho, E.-C., Sheahan, S., Edelmann, M., Kessler, B., & La Thangue, N. B. (2008) · Nature Cell Biology · doi:10.1038/ncb1802 · Cited by 462
Skp2 Regulates Myc Protein Stability and Activity
Kim, S. Y., Herbst, A., Tworkowski, K. A., Salghetti, S. E., & Tansey, W. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00173-4 · Cited by 440
Linking cyclins to transcriptional control
Coqueret, O. (2002) · Gene · doi:10.1016/s0378-1119(02)01055-7 · Cited by 431
Requirement for CDK4 kinase function in breast cancer
Yu, Q., Sicinska, E., Geng, Y., Ahnström, M., Zagozdzon, A., Kong, Y., Gardner, H., Kiyokawa, H., Harris, L. N., Stål, O., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.012 · Cited by 429
Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 CIP1/WAF1 and cyclin D proteins
Yu, Z.-K., Gervais, J. L. M., & Zhang, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11324 · Cited by 411
Cyclin D1 in Breast Cancer Pathogenesis
Arnold, A., & Papanikolaou, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.064 · Cited by 411
Aktas, H., Cai, H., & Cooper, G. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3850 · Cited by 410
von der Lehr, N., Johansson, S., Wu, S., Bahram, F., Castell, A., Cetinkaya, C., Hydbring, P., Weidung, I., Nakayama, K., Nakayama, K. I., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00193-x · Cited by 408
WEBER, J. D., RABEN, D. M., PHILLIPS, P. J., & BALDASSARE, J. J. (1997) · Biochemical Journal · doi:10.1042/bj3260061 · Cited by 406
Agami, R., & Bernards, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00010-6 · Cited by 390
Bandi, N., Zbinden, S., Gugger, M., Arnold, M., Kocher, V., Hasan, L., Kappeler, A., Brunner, T., & Vassella, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4277 · Cited by 386
Cyclin D1: polymorphism, aberrant splicing and cancer risk
Knudsen, K. E., Diehl, J. A., Haiman, C. A., & Knudsen, E. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209371 · Cited by 363
Self-citationPhosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex
Lin, D. I., Barbash, O., Kumar, K. G. S., Weber, J. D., Harper, J. W., Klein-Szanto, A. J. P., Rustgi, A., Fuchs, S. Y., & Diehl, J. A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.09.007 · Cited by 349
Self-citationLee, R. J., Albanese, C., Fu, M., D'Amico, M., Lin, B., Watanabe, G., Haines, G. K., Siegel, P. M., Hung, M.-C., Yarden, Y., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.672-683.2000 · Cited by 347
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J. E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y. E., Clark, A. B., et al. (2011) · Nature · doi:10.1038/nature10155 · Cited by 333
Catalytic Control in the EGF Receptor and Its Connection to General Kinase Regulatory Mechanisms
Jura, N., Zhang, X., Endres, N. F., Seeliger, M. A., Schindler, T., & Kuriyan, J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.004 · Cited by 310
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
Zwijsen, R. M. L., Buckle, R. S., Hijmans, E. M., Loomans, C. J. M., & Bernards, R. (1998) · Genes & Development · doi:10.1101/gad.12.22.3488 · Cited by 305
F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage
Santra, M. K., Wajapeyee, N., & Green, M. R. (2009) · Nature · doi:10.1038/nature08011 · Cited by 284
Role of the F-box protein Skp2 in lymphomagenesis
Latres, E., Chiarle, R., Schulman, B. A., Pavletich, N. P., Pellicer, A., Inghirami, G., & Pagano, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041475098 · Cited by 279
Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression
Brewer, J. W., Hendershot, L. M., Sherr, C. J., & Diehl, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8505 · Cited by 276
Self-citationLiu, J.-J., Chao, J.-R., Jiang, M.-C., Ng, S.-Y., Yen, J. J.-Y., & Yang-Yen, H.-F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3654 · Cited by 275
The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma
Sheppard, K. E., & McArthur, G. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0259 · Cited by 265
Molecular prognostic markers in pancreatic cancer: A systematic review
Garcea, G., Neal, C. P., Pattenden, C. J., Steward, W. P., & Berry, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.044 · Cited by 259
Wiestner, A., Tehrani, M., Chiorazzi, M., Wright, G., Gibellini, F., Nakayama, K., Liu, H., Rosenwald, A., Muller-Hermelink, H. K., Ott, G., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039859 · Cited by 252
Hamanaka, R. B., Bennett, B. S., Cullinan, S. B., & Diehl, J. A. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-03-0268 · Cited by 250
Self-citationCyclin D1 in non-small cell lung cancer: A key driver of malignant transformation
Gautschi, O., Ratschiller, D., Gugger, M., Betticher, D. C., & Heighway, J. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.09.024 · Cited by 243
Aggarwal, P., Vaites, L. P., Kim, J. K., Mellert, H., Gurung, B., Nakagawa, H., Herlyn, M., Hua, X., Rustgi, A. K., McMahon, S. B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.012 · Cited by 242
Self-citationAn alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu, F., Gladden, A. B., & Diehl, J. A. (2003) · PubMed · Cited by 239
Self-citationCyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression
Lee, Y., Dominy, J. E., Choi, Y. J., Jurczak, M., Tolliday, N., Camporez, J. P., Chim, H., Lim, J.-H., Ruan, H.-B., Yang, X., et al. (2014) · Nature · doi:10.1038/nature13267 · Cited by 234
FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
Zona, S., Bella, L., Burton, M. J., Nestal de Moraes, G., & Lam, E. W.-F. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.016 · Cited by 225
Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.
Kato, J. Y., & Sherr, C. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11513 · Cited by 220
Solomon, D. A., Wang, Y., Fox, S. R., Lambeck, T. C., Giesting, S., Lan, Z., Senderowicz, A. M., & Knudsen, E. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303969200 · Cited by 218
Oki, T., Nishimura, K., Kitaura, J., Togami, K., Maehara, A., Izawa, K., Sakaue-Sawano, A., Niida, A., Miyano, S., Aburatani, H., et al. (2014) · Scientific Reports · doi:10.1038/srep04012 · Cited by 216
Wang, C., Li, Z., Lu, Y., Du, R., Katiyar, S., Yang, J., Fu, M., Leader, J. E., Quong, A., Novikoff, P. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603363103 · Cited by 208
Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma
Thomas, G. R., Nadiminti, H., & Regalado, J. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00447.x · Cited by 204
Inuzuka, H., Tseng, A., Gao, D., Zhai, B., Zhang, Q., Shaik, S., Wan, L., Ang, X. L., Mock, C., Yin, H., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.015 · Cited by 204
p21Cip1 Promotes Cyclin D1 Nuclear Accumulation via Direct Inhibition of Nuclear Export
Alt, J. R., Gladden, A. B., & Diehl, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108867200 · Cited by 202
Self-citationFranco, J., Balaji, U., Freinkman, E., Witkiewicz, A. K., & Knudsen, E. S. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.094 · Cited by 199
Knudsen, K. E., Cavenee, W. K., & Arden, K. C. (1999) · PubMed · Cited by 191
The crystal structure of cyclin A
Brown, N., Noble, M., Endicott, J., Garman, E., Wakatsuki, S., Mitchell, E., Rasmussen, B., Hunt, T., & Johnson, L. (1995) · Structure · doi:10.1016/s0969-2126(01)00259-3 · Cited by 191
Treinies, I., Paterson, H. F., Hooper, S., Wilson, R., & Marshall, C. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.321 · Cited by 189
Molecular pathogenesis of head and neck squamous cell carcinoma
Hardisson, D. (2003) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-003-0581-3 · Cited by 186
Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present
Casimiro, M. C., Velasco-Velázquez, M., Aguirre-Alvarado, C., & Pestell, R. G. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.867017 · Cited by 184
Takuwa, N., Fukui, Y., & Takuwa, Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1346 · Cited by 182
Cyclin D1 Regulates Cellular Migration through the Inhibition of Thrombospondin 1 and ROCK Signaling
Li, Z., Wang, C., Jiao, X., Lu, Y., Fu, M., Quong, A. A., Dye, C., Yang, J., Dai, M., Ju, X., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02124-05 · Cited by 177
Warburg effect(s)—a biographical sketch of Otto Warburg and his impacts on tumor metabolism
Otto, A. M. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0145-9 · Cited by 177
FOXM1: A key oncofoetal transcription factor in health and disease
Bella, L., Zona, S., Nestal de Moraes, G., & Lam, E. W.-F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.008 · Cited by 171
Alternative Splicing of the Cyclin D1 Proto-Oncogene Is Regulated by the RNA-Binding Protein Sam68
Paronetto, M. P., Cappellari, M., Busà, R., Pedrotti, S., Vitali, R., Comstock, C., Hyslop, T., Knudsen, K. E., & Sette, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2788 · Cited by 167
Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1
Benzeno, S., Lu, F., Guo, M., Barbash, O., Zhang, F., Herman, J. G., Klein, P. S., Rustgi, A. K., & Diehl, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209644 · Cited by 167
Self-citationPalbociclib: First Global Approval
Dhillon, S. (2015) · Drugs · doi:10.1007/s40265-015-0379-9 · Cited by 165
Induction of Cell Proliferation in Quiescent NIH 3T3 Cells by Oncogenic c-Raf-1
Kerkhoff, E., & Rapp, U. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2576 · Cited by 162
The role of cell cycle regulatory proteins in the pathogenesis of melanoma
Li, W., Sanki, A., Karim, R. Z., Thompson, J. F., Lee, C. S., Zhuang, L., McCarthy, S. W., & Scolyer, R. A. (2006) · Pathology · doi:10.1080/00313020600817951 · Cited by 158
RSK1 drives p27 Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility
Larrea, M. D., Hong, F., Wander, S. A., Silva, T. G. D., Helfman, D. M., Lannigan, D. A., Smith, J. A., & Slingerland, J. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805057106 · Cited by 150
PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers
Li, Y., Chitnis, N., Nakagawa, H., Kita, Y., Natsugoe, S., Yang, Y., Li, Z., Wasik, M., Klein-Szanto, A. J. P., Rustgi, A. K., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0625 · Cited by 143
Self-citationBarbash, O., Zamfirova, P., Lin, D. I., Chen, X., Yang, K., Nakagawa, H., Lu, F., Rustgi, A. K., & Diehl, J. A. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.017 · Cited by 140
Self-citationMiao, B., Skidan, I. N., Yang, J., Lugovskoy, A. A., Reibarkh, M., Long, K., Brazell, T., Durugkar, K. A., Maki, J. L., Ramana, C. V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004522107 · Cited by 138
Targeting cell cycle regulators in hematologic malignancies
Aleem, E. A., & Arceci, R. J. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00016 · Cited by 137
Aggarwal, P., Lessie, M. D., Lin, D. I., Pontano, L., Gladden, A. B., Nuskey, B., Goradia, A., Wasik, M. A., Klein-Szanto, A. J. P., Rustgi, A. K., et al. (2007) · Genes & Development · doi:10.1101/gad.1586007 · Cited by 132
Self-citationInteraction of D-Type Cyclins with a Novel myb-Like Transcription Factor, DMP1
Hirai, H., & Sherr, C. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6457 · Cited by 131
Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma
Gladden, A. B., Woolery, R., Aggarwal, P., Wasik, M. A., & Diehl, J. A. (2005) · Oncogene · doi:10.1038/sj.onc.1209147 · Cited by 131
Self-citationCyclin D1 gene (CCND1) mutations in endometrial cancer
Moreno‐Bueno, G., Rodríguez, S., Sánchez‐Estévez, C., Hardisson, D., Sarrió, D., Prat, J., Cigudosa, J. C., Matías‐Guiu, X., & Palacios, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206868 · Cited by 125
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
Casimiro, M. C., Crosariol, M., Loro, E., Ertel, A., Yu, Z., Dampier, W., Saria, E. A., Papanikolaou, A., Stanek, T. J., Li, Z., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60256 · Cited by 115
Zhang, Y.-X., Sicinska, E., Czaplinski, J. T., Remillard, S. P., Moss, S., Wang, Y., Brain, C., Loo, A., Snyder, E. L., Demetri, G. D., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0387 · Cited by 114
Daniel, P. M., Filiz, G., Brown, D. V., Hollande, F., Gonzales, M. F., D’Abaco, G. M., Papalexis, N., Phillips, W. A., Malaterre, J., Ramsay, R. G., et al. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.21 · Cited by 113
Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line
Perry, J. E., Grossmann, M. E., & Tindall, D. J. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980501)35:2<117::aid-pros5>3.0.co;2-g · Cited by 111
Update on the molecular biology of mantle cell lymphoma
Bertoni, F., Rinaldi, A., Zucca, E., & Cavalli, F. (2006) · Hematological Oncology · doi:10.1002/hon.767 · Cited by 103
Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors
Lin, H., Zhao, L., & Cheng, S.-Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203380200 · Cited by 101
Changing gears in Nrf1 research, from mechanisms of regulation to its role in disease and prevention
Bugno, M., Daniel, M., Chepelev, N. L., & Willmore, W. G. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.08.001 · Cited by 86
Wnt1 and MEK1 Cooperate to Promote Cyclin D1 Accumulation and Cellular Transformation
Rimerman, R. A., Gellert-Randleman, A., & Diehl, J. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910241199 · Cited by 85
Self-citationPontano, L. L., Aggarwal, P., Barbash, O., Brown, E. J., Bassing, C. H., & Diehl, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01085-08 · Cited by 81
Self-citationWei, S., Yang, M., Chuang, H.-C., Yang, J., Kulp, S. K., Lu, P., Lai, M.-D., & Chen, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802160200 · Cited by 79
Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene
Olshavsky, N. A., Comstock, C. E. S., Schiewer, M. J., Augello, M. A., Hyslop, T., Sette, C., Zhang, J., Parysek, L. M., & Knudsen, K. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3468 · Cited by 77
State of the APC/C: Organization, function, and structure
McLean, J. R., Chaix, D., Ohi, M. D., & Gould, K. L. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.541420 · Cited by 76
Role of Pirh2 in Mediating the Regulation of p53 and c-Myc
Hakem, A., Bohgaki, M., Lemmers, B., Tai, E., Salmena, L., Matysiak‐Zablocki, E., Jung, Y.-S., Karásková, J., Kaustov, L., Duan, S., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002360 · Cited by 75
Hanse, E. A., Mashek, D. G., Becker, J. R., Solmonson, A., Mullany, L. K., Mashek, M. T., Towle, H. C., Chau, A. T., & Albrecht, J. H. (2012) · Cell Cycle · doi:10.4161/cc.21019 · Cited by 75
Genetic Reevaluation of the Role of F-Box Proteins in Cyclin D1 Degradation
Kanie, T., Onoyama, I., Matsumoto, A., Yamada, M., Nakatsumi, H., Tateishi, Y., Yamamura, S., Tsunematsu, R., Matsumoto, M., & Nakayama, K. I. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06570-11 · Cited by 74
Kupr, B., & Handschin, C. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00325 · Cited by 73
Lee, E. K., & Diehl, J. A. (2013) · Oncogene · doi:10.1038/onc.2013.144 · Cited by 72
Self-citationSmad3 phosphorylation by cyclin-dependent kinases
LIU, F. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.010 · Cited by 71
Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer
Yu, Z., Wang, L., Wang, C., Ju, X., Wang, M., Chen, K., Loro, E., Li, Z., Zhang, Y., Wu, K., et al. (2013) · Nature Communications · doi:10.1038/ncomms3812 · Cited by 70
Cyclin D1 Represses Gluconeogenesis via Inhibition of the Transcriptional Coactivator PGC1α
Bhalla, K., Liu, W.-J., Thompson, K. N., Anders, L., Devarakonda, S., Dewi, R. E., Buckley, S., Hwang, B., Polster, B. M., Dorsey, S. G., et al. (2014) · Diabetes · doi:10.2337/db13-1283 · Cited by 63
Tumor progression and the different faces of the PERK kinase
Pytel, D., Majsterek, I., & Diehl, J. A. (2015) · Oncogene · doi:10.1038/onc.2015.178 · Cited by 62
Self-citationWei, S., Lin, L.-F., Yang, C.-C., Wang, Y.-C., Chang, G.-D., Chen, H., & Chen, C. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035287 · Cited by 59
Cell-cycle dysregulation and the molecular mechanisms of prostate cancer
Derek, F. A. (2000) · Frontiers in bioscience · doi:10.2741/amanatullah · Cited by 57
The Fbx4 Tumor Suppressor Regulates Cyclin D1 Accumulation and Prevents Neoplastic Transformation
Vaites, L. P., Lee, E. K., Lian, Z., Barbash, O., Roy, D. B., Wasik, M. A., Klein–Szanto, A. J., Rustgi, A. K., & Diehl, J. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05733-11 · Cited by 55
Self-citationCDK4/6 inhibitors in breast cancer
Dukelow, T., Kishan, D., Khasraw, M., & Murphy, C. G. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000249 · Cited by 53
Yang, C.-C., Wang, Y.-C., Wei, S., Lin, L.-F., Chen, C., Lee, C.-C., Lin, C., & Chen, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2759 · Cited by 50
Molecular alterations associated with cyclin d1 overexpression in endometrial cancer
Moreno‐Bueno, G., Rodríguez, S., Sánchez‐Estévez, C., Marcos, R., Hardisson, D., Cigudosa, J. C., & Palacios, J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20130 · Cited by 49
Poch, B., Gansauge, F., Schwarz, A., Seufferlein, T. T. W., Schnelldorfer, T., Ramadani, M., Beger, H. G., & Gansauge, S. (2001) · Pancreas · doi:10.1097/00006676-200110000-00009 · Cited by 48
The FBXO4 Tumor Suppressor Functions as a Barrier to Braf V600E -Dependent Metastatic Melanoma
Lee, E. K., Lian, Z., D'Andrea, K. P., Letrero, R., Sheng, W., Liu, S., Diehl, J. A., Pytel, D., Barbash, O., Schuchter, L. M., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00706-13 · Cited by 39
Self-citationLi, R., An, S., Chen, Z. H., Zhang, G.-C., Zhu, J.-Q., Nie, Q., Xie, Z., Guo, A., Mok, T. S. K., & Wu, Y.-L. L. C. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.05.008 · Cited by 37
Tarasewicz, E., Rivas, L., Hamdan, R., Đokić, D., Parimi, V., Bernabé, B. P., Thomas, A., Shea, L. D., & Jeruss, J. S. (2014) · Cell Cycle · doi:10.4161/15384101.2014.950126 · Cited by 35
Barbash, O., Lee, E. K., & Diehl, J. A. (2011) · Oncogene · doi:10.1038/onc.2010.584 · Cited by 33
Self-citationA family outing: small GTPases cyclin' through G1
Coleman, M. L., & Marshall, C. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-e250 · Cited by 28
Xu, Y., Li, H., Huang, C., Zhao, T., Zhang, H., Zheng, C., Ren, H., & Hao, J. (2015) · Medical Oncology · doi:10.1007/s12032-015-0513-2 · Cited by 28
Wu, W.-H., Slomovitz, B. M., Soliman, P. T., Schmeler, K., Celestino, J., Milam, M. R., & Lu, K. H. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00642.x · Cited by 23
Vaites, L. P., Lian, Z., Lee, E. K., Yin, B., DeMicco, A., Bassing, C. H., & Diehl, J. A. (2013) · Oncogene · doi:10.1038/onc.2012.577 · Cited by 22
Self-citationUbiquitin-Dependent Proteolysis in G1/S Phase Control and Its Relationship with Tumor Susceptibility
Diehl, J. A., & Ponugoti, B. (2010) · Genes & Cancer · doi:10.1177/1947601910382902 · Cited by 22
Self-citationRegulation of cell fate determination by Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligases
Hindley, C. J., McDowell, G. S., Wise, H. M., & Philpott, A. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103171ch · Cited by 20
Alternative splicing variants of human Fbx4 disturb cyclin D1 proteolysis in human cancer
Chu, X., Zhang, T., Wang, J., Li, M., Zhang, X., Tu, J., Sun, S., Chen, X., & Lu, F. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.129 · Cited by 18
PRMT5-dependent p53 escape in tumorigenesis
Li, Y., & Diehl, J. A. (2015) · Oncoscience · doi:10.18632/oncoscience.222 · Cited by 13
Self-citation
Cited by
Montalto, F. I., & De Amicis, F. (2020) · Cells · doi:10.3390/cells9122648 · Cited by 496
CDK4 and CDK6 kinases: From basic science to cancer therapy
Fassl, A., Geng, Y., & Sicinski, P. (2022) · Science · doi:10.1126/science.abc1495 · Cited by 464
Liu, Y., Zheng, C., Huang, Y., He, M., Xu, W. W., & Li, B. (2021) · MedComm · doi:10.1002/mco2.55 · Cited by 387
β-Catenin signaling in hepatocellular carcinoma
Xu, C., Xu, Z., Zhang, Y., Evert, M., Calvisi, D. F., & Chen, X. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154515 · Cited by 305
The double dealing of cyclin D1
Tchakarska, G., & Sola, B. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1706903 · Cited by 278
Metadata
- Authors
- Qie, S., & Diehl, J. A.
- Venue
- Journal of Molecular Medicine
- Published
- 2016-10-02
- Volume
- 94
- Issue
- 12
- Pages
- 1313-1326
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2527438532
- Cited by
- 657
- References
- 139
- FWCI
- 19.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.